Abstract
Background SF-36 is a popular questionnaire for measuring self-perception of quality of life in a given population of interest. Surprisingly, no study compared score values issued from a telephone interview versus an internet-based questionnaire self-completion.
Methods Patients having an Internet connection and returning home after hospital discharge were enrolled in the SENTIPAT multicenter randomized trial the day of discharge. They were randomized to either self-complete a set of questionnaires using a dedicated website (I group) or to provide answers to the same questionnaires administered during a telephone interview (T group). This ancillary study of the trial compared SF-36 data relating to the post-hospitalization period in these two groups. In order to anticipate potential unbalanced characteristics of the respondents in the two groups, the impact of the mode of administration of the questionnaire on score differences was investigated using a matched sample of individuals originating from I and T groups (ratio 1:1), the matching procedure being based on a propensity score approach. SF-36 scores observed in I and T groups were compared with a Wilcoxon-Mann-Whitney test, the score differences between the two groups were also examined according to Cohen’s effect size.
Results There were 245/840 (29%) and 630/840 (75%) SF-36 questionnaires completed in the I and T group, respectively (p < 0.001). Globally, score differences between groups before matching were similar to those observed in the matched sample. Mean scores observed in T group were all above the corresponding values observed in the I group. After matching, score differences in six out of the eight SF-36 scales were statistically significant, with a mean difference greater than 5 for four scales and an associated mild effect size ranging from 0.22 to 0.29, and with a mean difference near this threshold for two other scales (4.57 and 4.56) and a low corresponding effect size (0.18 and 0.16, respectively).
Conclusions Telephone mode of administration of SF-36 involved an interviewer effect increasing SF-36 scores. Questionnaire self-completion via the Internet should be preferred and surveys combining various administration methods should be avoided.
Trial Registration ClinicalTrials.gov NCT01769261, registered January 16, 2013.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov NCT01769261
Clinical Protocols
https://clinicaltrials.gov/ct2/show/NCT01769261
Funding Statement
The Assistance Publique-Hôpitaux de Paris (Département de la Recherche Clinique et du Développement) was the trial sponsor. The SENTIPAT study was funded by grant AOM09213 K081204 from Programme Hospitalier de la Recherche Clinique 2009 (Ministère de la Santé). The sponsor and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The SENTIPAT study was approved by the Comité de Protection des Personnes Ile de France IX (decision CPP-IDF IX 12-014, June 12, 2012); by the Comité Consultatif sur le Traitement de l'Information en matière de Recherche dans le domaine de la Santé (decision 12.365, June 20, 2012); and by the Commission Nationale de l'Informatique et des Libertés (decision DR-2012-582, December 12, 2012).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(ayse.acma{at}gmail.com)
(fabrice.carrat{at}iplesp.upmc.fr)
Email addresses: AA: ayse.acma{at}gmail.com
FC: fabrice.carrat{at}iplesp.upmc.fr
GH: gilles.hejblum{at}inserm.fr
Data Availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.
